Sperm cell biology: current perspectives and future prospects.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Effects of in vitro repaglinide supplementation on improving sperm motility parameters, viability, and DNA integrity in normozoospermic and asthenozoospermic men.JBRA assisted reproduction · 2023
   Article
2. Specific loss of CatSper function is sufficient to compromise fertilizing capacity of human spermatozoa.Human reproduction (Oxford, England) · 2015
   Article
3. Sperm DNA oxidative damage and DNA adducts.Mutation research. Genetic toxicology and environmental mutagenesis · 2015
   Article
4. The clinical significance of calcium-signalling pathways mediating human sperm hyperactivation.Human reproduction (Oxford, England) · 2013
   Article
5. An update on the clinical assessment of the infertile male. [corrected].Clinics (Sao Paulo, Brazil) · 2011
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as